BARD1 mutation carriers in our study were more likely to have a family history of liver, prostate, and cervical cancers than patients who tested negative for the 30 gene panel (p-values = 0.04, 0.018, and 0.037, respectively). This evidence concerns the gene BARD1 and cervical cancer.